CN115089628A - 一种治疗冠心病的中药颗粒 - Google Patents
一种治疗冠心病的中药颗粒 Download PDFInfo
- Publication number
- CN115089628A CN115089628A CN202210806093.1A CN202210806093A CN115089628A CN 115089628 A CN115089628 A CN 115089628A CN 202210806093 A CN202210806093 A CN 202210806093A CN 115089628 A CN115089628 A CN 115089628A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- ligusticum wallichii
- decoction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 28
- 239000008187 granular material Substances 0.000 title claims abstract description 28
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 25
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 24
- 241000545744 Hirudinea Species 0.000 claims abstract description 19
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 19
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 19
- 239000000047 product Substances 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000706 filtrate Substances 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 238000000227 grinding Methods 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 238000004806 packaging method and process Methods 0.000 claims abstract description 6
- 239000002245 particle Substances 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 238000007873 sieving Methods 0.000 claims abstract description 6
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract 9
- 239000007788 liquid Substances 0.000 claims description 5
- 208000002193 Pain Diseases 0.000 description 15
- 230000036407 pain Effects 0.000 description 15
- 244000132619 red sage Species 0.000 description 15
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 206010002383 Angina Pectoris Diseases 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010042674 Swelling Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000003674 animal food additive Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000010515 dystocia Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗冠心病的中药颗粒,其由以下重量份的原料组成:丹参6‑10份、川芎5‑9份、三七3‑5份、水蛭1‑3份;所述中药颗粒的制备方法包括以下步骤:步骤1)取用三七、水蛭,并碾成100~120目的细粉,备用;步骤2)取用丹参、川芎进行两次煎煮,第一次煎煮加水量为丹参、川芎总重量的3‑5倍,煎煮60min,取其药液;第二次煎煮,再次加水,加水量为丹参、川芎总重量的3‑4倍,煎煮50min;将两次煎煮提取液合并过滤,取其滤液;步骤3)将步骤2所得滤液放入浓缩罐中进行浓缩至膏状,再加入步骤1所得细粉,控制80℃温度进行低温烘干,将烘干所得物进行粉碎,并过60目筛,可得颗粒物;步骤4)以每袋10g为单位进行密封包装,可得成品。
Description
技术领域
本发明涉及一种中药颗粒,具体是指一种治疗冠心病的中药颗粒。
背景技术
冠心病是一种严重危害人类身体健康的心血管疾病,临床上为常见病、多发病。用中医药对冠心病的治疗研究和预防研究是医学领域的一项重要的课题。近年来,中医药在治疗本病方面取得长足进展,成为冠心病的综合治疗的手段之一。鉴于冠心病为临床常见病、多发病,加强对其的治疗研究已成为临床工作者的首要任务;
中药治疗冠心病心胶痛有阒悠久的历史和丰富的经验。中医的整体观念、辨症施治、动态平衡及中医学治疗本病的有效性、无害性、持续性、多样性等优势适宜于复杂多样的冠心病的治疗。多向研究观察业已证实,在发送症状,降低复发,提高生活质量方面中药医疗效确切明显。长期服用中药可寓防于治,集预防、治疗、康复于一体,是当前治疗冠心病取得某些突破最有希望的方法之一。因此,充分发挥祖国医学的优势,结合现代研究成果,寻求与研制治疗冠心病的有效方剂,具有十分重要的理论意义与使用价值。
发明内容
本发明要解决的技术问题是克服上述技术的缺陷,提供一种治疗冠心病的中药颗粒。
为解决上述技术问题,本发明提供的技术方案为一种治疗冠心病的中药颗粒,其由以下重量份的原料组成:丹参6-10份、川芎5-9份、三七3-5份、水蛭1-3份。
进一步地,其由以下重量份的原料组成:丹参6份、川芎5份、三七3份、水蛭1份。
进一步地,其由以下重量份的原料组成:丹参8份、川芎7份、三七4份、水蛭2份。
进一步地,其由以下重量份的原料组成:丹参10份、川芎59份、三七5份、水蛭3份。
进一步地,所述中药颗粒的制备方法包括以下步骤:
步骤1)取用三七、水蛭,并碾成100~120目的细粉,备用;
步骤2)取用丹参、川芎进行两次煎煮,第一次煎煮加水量为丹参、川芎总重量的3-5倍,煎煮60min,取其药液;第二次煎煮,再次加水,加水量为丹参、川芎总重量的3-4倍,煎煮50min;将两次煎煮提取液合并过滤,取其滤液;
步骤3)将步骤2所得滤液放入浓缩罐中进行浓缩至膏状,再加入步骤1所得细粉,控制80℃温度进行低温烘干,将烘干所得物进行粉碎,并过60目筛,可得颗粒物;
步骤4)以每袋10g为单位进行密封包装,可得成品。
本发明所用原料来源如下:
丹参:味苦,微寒;归心、肝经;活血祛瘀,通经止痛,清心除烦,凉血消痈;用于胸痹心痛,脘腹胁痛,症瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛。
川芎:味辛,温;入肝、胆经;行气开郁,祛除风燥湿,活血止痛。治风冷头痛旋晕,胁痛腹疼,寒痹筋挛,经闭,难产,产后瘀阻块痛,痈疽疮疡;用于月经不调,经闭痛经,瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。
三七:甘、微苦,温;归肝、胃经;散瘀止血,消肿定痛;用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹刺痛,跌扑肿痛。
水蛭:咸、苦,平;归肝经;破血通经,逐瘀消癥;用于血瘀经闭,癥瘕痞块,中风偏瘫,跌扑损伤。
本发明与现有技术相比的优点在于:本发明所提供的中药颗粒配方,全方结构合理,配伍精当,无明显毒副作用,具有活血化瘀,宽胸理气,防止血栓形成,疏通冠状动脉,从而达到通则不痛的效果。
具体实施方式
下面结合实施例对本发明一种治疗冠心病的中药颗粒做进一步的详细说明。
实施例1
一种治疗冠心病的中药颗粒,其由以下重量份的原料组成:丹参6份、川芎5份、三七3份、水蛭1 份;
所述中药颗粒的制备方法包括以下步骤:
步骤1)取用三七、水蛭,并碾成100~120目的细粉,备用;
步骤2)取用丹参、川芎进行两次煎煮,第一次煎煮加水量为丹参、川芎总重量的3-5倍,煎煮60min,取其药液;第二次煎煮,再次加水,加水量为丹参、川芎总重量的3-4倍,煎煮50min;将两次煎煮提取液合并过滤,取其滤液;
步骤3)将步骤2所得滤液放入浓缩罐中进行浓缩至膏状,再加入步骤1所得细粉,控制80℃温度进行低温烘干,将烘干所得物进行粉碎,并过60目筛,可得颗粒物;
步骤4)以每袋10g为单位进行密封包装,可得成品。
实施例2
一种治疗冠心病的中药颗粒,其由以下重量份的原料组成:丹参8份、川芎7份、三七4份、水蛭2 份;
所述中药颗粒的制备方法包括以下步骤:
步骤1)取用三七、水蛭,并碾成100~120目的细粉,备用;
步骤2)取用丹参、川芎进行两次煎煮,第一次煎煮加水量为丹参、川芎总重量的3-5倍,煎煮60min,取其药液;第二次煎煮,再次加水,加水量为丹参、川芎总重量的3-4倍,煎煮50min;将两次煎煮提取液合并过滤,取其滤液;
步骤3)将步骤2所得滤液放入浓缩罐中进行浓缩至膏状,再加入步骤1所得细粉,控制80℃温度进行低温烘干,将烘干所得物进行粉碎,并过60目筛,可得颗粒物;
步骤4)以每袋10g为单位进行密封包装,可得成品。
实施例3
一种治疗冠心病的中药颗粒,其由以下重量份的原料组成:丹参10份、川芎59份、三七5份、水蛭 3份;
所述中药颗粒的制备方法包括以下步骤:
步骤1)取用三七、水蛭,并碾成100~120目的细粉,备用;
步骤2)取用丹参、川芎进行两次煎煮,第一次煎煮加水量为丹参、川芎总重量的3-5倍,煎煮60min,取其药液;第二次煎煮,再次加水,加水量为丹参、川芎总重量的3-4倍,煎煮50min;将两次煎煮提取液合并过滤,取其滤液;
步骤3)将步骤2所得滤液放入浓缩罐中进行浓缩至膏状,再加入步骤1所得细粉,控制80℃温度进行低温烘干,将烘干所得物进行粉碎,并过60目筛,可得颗粒物;
步骤4)以每袋10g为单位进行密封包装,可得成品。
实施例4临床实验
1、诊断标准
诊断参照1980年全国内科学术会议,"冠心病命名及诊断标准的建议"诊断与分型[中华内科杂志1981, 20(4)∶253],选择有心胶痛反复发作,常规心电图有缺血性ST-T改变者,全部病例均有程度不等的心悸,气短,胸闷和胸痛而确诊者。
2、实验分组
治疗组50例,其中男32例,女18例,年龄42-76岁,平均年龄59岁,劳力性心绞痛31例,非劳力性心绞痛19例,合并高血压10例,糖尿病4例,心律失常3例,轻度10例,中度35例,重度5例;
对照组30例,其中男20例,女10例,年龄40-70岁,平均年龄55岁,劳力性心绞痛19例,非劳力性心绞痛11例,合并高血压6例,糖尿病3例,心律失常4例,轻度6例,中度22例,重度2例。
两组发病年龄、疼痛类型及程度均有可比性(P>0.05)。
3、治疗方法
治疗组采用本发明实施例1所制备的中药颗粒,每次1袋10克,每天2次,放玻璃杯里用温开水融化后服用,30天为一个疗程。
对照组每次口服市售治疗冠心病药物消心痛10mg,潘生丁50mg,每天3次,30天为一个疗程。
两组服药期间均停用其它治疗冠心病心绞痛药物,一个疗程后评定疗效。
4、治疗结果
1)疗效评定标准
显效∶1个疗程后,各症状、体征消失及心电图ST-T恢复正常。
好转∶1个疗程后,临床症状、体征明显减轻或消失,心电图ST-T段的降低在治疗后回升0.05mv以上,但未达正常水平。
无效∶1个疗程后,临床症状及心电图无任何改变。
2)实验结果
治疗组50例中,显效40例,好转10例,总有效率100%。
对照组30例中,显效8例,好转18例,无效4例,总有效率86.6%。
两组比较治疗组总有效率明显优于对照组(P<0.01)。
采用本发明实施例2及实施例3所制备的中药颗粒,进行上述实验,得出实验结果与上述总体趋势一致。
通过上述实验可知,本发明所提供的中药颗粒配方,全方结构合理,配伍精当,无明显毒副作用,具有活血化瘀,宽胸理气,防止血栓形成,疏通冠状动脉,从而达到通则不痛的效果。
以上对本发明及其实施方式进行了描述,这种描述没有限制性。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。
Claims (5)
1.一种治疗冠心病的中药颗粒,其特征在于,其由以下重量份的原料组成:丹参6-10份、川芎5-9份、三七3-5份、水蛭1-3份。
2.根据权利要求1所述的一种治疗冠心病的中药颗粒,其特征在于,其由以下重量份的原料组成:丹参6份、川芎5份、三七3份、水蛭1份。
3.根据权利要求1所述的一种治疗冠心病的中药颗粒,其特征在于,其由以下重量份的原料组成:丹参8份、川芎7份、三七4份、水蛭2份。
4.根据权利要求1所述的一种治疗冠心病的中药颗粒,其特征在于,其由以下重量份的原料组成:丹参10份、川芎59份、三七5份、水蛭3份。
5.根据权利要求1-4任意一项所述的一种治疗冠心病的中药颗粒,其特征在于,所述中药颗粒的制备方法包括以下步骤:
步骤1)取用三七、水蛭,并碾成100~120目的细粉,备用;
步骤2)取用丹参、川芎进行两次煎煮,第一次煎煮加水量为丹参、川芎总重量的3-5倍,煎煮60min,取其药液;第二次煎煮,再次加水,加水量为丹参、川芎总重量的3-4倍,煎煮50min;将两次煎煮提取液合并过滤,取其滤液;
步骤3)将步骤2所得滤液放入浓缩罐中进行浓缩至膏状,再加入步骤1所得细粉,控制80℃温度进行低温烘干,将烘干所得物进行粉碎,并过60目筛,可得颗粒物;
步骤4)以每袋10g为单位进行密封包装,可得成品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210806093.1A CN115089628A (zh) | 2022-07-08 | 2022-07-08 | 一种治疗冠心病的中药颗粒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210806093.1A CN115089628A (zh) | 2022-07-08 | 2022-07-08 | 一种治疗冠心病的中药颗粒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115089628A true CN115089628A (zh) | 2022-09-23 |
Family
ID=83296812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210806093.1A Pending CN115089628A (zh) | 2022-07-08 | 2022-07-08 | 一种治疗冠心病的中药颗粒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115089628A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1679639A (zh) * | 2005-01-25 | 2005-10-12 | 王维和 | 活血中药三七和水蛭提取物制备的口服软胶囊药物制剂 |
CN1686384A (zh) * | 2005-04-11 | 2005-10-26 | 北京正大绿洲医药科技有限公司 | 一种治疗心脏病的冠心宁滴丸及其制备方法 |
CN1733242A (zh) * | 2005-09-02 | 2006-02-15 | 保定中药制药有限公司 | 一种治疗气虚血瘀型胸痹(冠心病)的药物及其制备工艺 |
CN1799577A (zh) * | 2005-01-04 | 2006-07-12 | 贵州渝生制药有限公司 | 治疗冠心病、心绞痛等心血管病的中药制剂其制作方法 |
CN105998295A (zh) * | 2016-07-30 | 2016-10-12 | 孙丰卿 | 一种治疗冠心病的中药组合物及其制剂的制备方法 |
-
2022
- 2022-07-08 CN CN202210806093.1A patent/CN115089628A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1799577A (zh) * | 2005-01-04 | 2006-07-12 | 贵州渝生制药有限公司 | 治疗冠心病、心绞痛等心血管病的中药制剂其制作方法 |
CN1679639A (zh) * | 2005-01-25 | 2005-10-12 | 王维和 | 活血中药三七和水蛭提取物制备的口服软胶囊药物制剂 |
CN1686384A (zh) * | 2005-04-11 | 2005-10-26 | 北京正大绿洲医药科技有限公司 | 一种治疗心脏病的冠心宁滴丸及其制备方法 |
CN1733242A (zh) * | 2005-09-02 | 2006-02-15 | 保定中药制药有限公司 | 一种治疗气虚血瘀型胸痹(冠心病)的药物及其制备工艺 |
CN105998295A (zh) * | 2016-07-30 | 2016-10-12 | 孙丰卿 | 一种治疗冠心病的中药组合物及其制剂的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102579918B (zh) | 治疗青光眼的中药组合物、制备方法及给药方式 | |
CN103083400A (zh) | 一种治疗心血管疾病的药物 | |
CN104873705A (zh) | 一种治疗冠心病心绞痛的药物组合物及其应用 | |
CN108653563A (zh) | 一种治疗冠心病的养心膏及其制备方法 | |
CN115089628A (zh) | 一种治疗冠心病的中药颗粒 | |
CN105687788A (zh) | 一种软化血管的药物组合物及其应用 | |
CN107260978B (zh) | 一种治疗高血压的中药组合物及其制备方法和用途 | |
CN111603534A (zh) | 一种治疗冠心病的中药颗粒剂及其制备方法 | |
CN111529659A (zh) | 治疗缓慢性心律失常的中药组合物及其制备方法和应用 | |
CN104338052A (zh) | 治疗脑血栓的中药配方 | |
CN109172624A (zh) | 一种治疗缺血性脑卒中的药物组合物及其应用 | |
CN116327825B (zh) | 一种用于治疗心血管疾病的中药及其制备方法 | |
CN112206279B (zh) | 一种治疗室性心律失常的中药组合物及其制备方法和应用 | |
CN102935162A (zh) | 一种用于球后视神经炎症的药丸及制备方法 | |
CN113679781B (zh) | 一种治疗快速性心律失常的中药组合物及其制备方法和应用 | |
CN114767816B (zh) | 一种治疗冠心病的中药组合物及其制备方法 | |
CN103041036B (zh) | 一种用于治疗三叉神经痛的丸剂 | |
CN106620206B (zh) | 一种治疗动脉粥样硬化的中药 | |
CN106880819A (zh) | 一种治疗高血压病的中药 | |
CN113082122A (zh) | 治疗阵发性房颤的中药组合物及其制备方法和应用 | |
CN114569676A (zh) | 一种治疗新型冠状病毒的药物及其制备方法 | |
CN104288377A (zh) | 一种治疗脑血栓的药物组合物 | |
CN116211940A (zh) | 治疗阵发性房颤的中药组合物及其制备方法 | |
CN105125886A (zh) | 一种用于预防和治疗糖尿病及其并发症的中药组合物 | |
CN116983359A (zh) | 治疗糖尿病合并冠心病稳定型心绞痛的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220923 |